Acrodermatitis continua of Hallopeau: evolution of treatment options

Int J Dermatol. 2011 Oct;50(10):1195-211. doi: 10.1111/j.1365-4632.2011.04993.x.


Ever since its inception, acrodermatitis continua of Hallopeau, has been recognized as an uncommon clinical entity which has been sparingly reported from across the globe. The attempt to have cumulative information on prevalent nomenclature, definition, reminiscences, and clinical overtures has brought differential diagnosis and diagnosis in sharp focus, the highlights of which are outlined. Hence, it was considered important to review the evolution of treatment options available thus far including use of biologics.

Publication types

  • Review

MeSH terms

  • Acrodermatitis / diagnosis
  • Acrodermatitis / pathology
  • Acrodermatitis / therapy*
  • Biological Products / therapeutic use
  • Dermatologic Agents / therapeutic use
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Phototherapy
  • Psoriasis / diagnosis
  • Psoriasis / pathology
  • Psoriasis / therapy
  • Treatment Outcome


  • Biological Products
  • Dermatologic Agents